Pontifax portfolio
Pontifax (Venture capital) is known to hold 54 companies, 12 of them startups. 6 of them are hiring now, with 103 open roles. Its companies closed 5 venture rounds in 12 months, raising $224.6M. Most of them work in Oncology Therapeutics, Biologics & Biosimilars, Drug Discovery.
Companies Pontifax has invested in
Open roles at Pontifax portfolio companies
Focus
Co-investors
Similar investors
their companies share markets and countries
Questions about Pontifax
How many companies has Pontifax invested in?
Pontifax is known to hold 54 companies: 12 startups, and 18 exits so far, read from its own portfolio page and the funding rounds that name it.
Is Pontifax investing now?
Pontifax has no round in the press in 12 months and no new company on its portfolio page in 90 days.
What does Pontifax invest in?
The markets of the companies Pontifax holds: Oncology Therapeutics (7%), Biologics & Biosimilars (6%), Drug Discovery (6%), Rare Disease Therapeutics (6%), Neurology & CNS Therapeutics (4%).
Which Pontifax portfolio companies are hiring?
6 companies Pontifax holds are hiring now, with 103 open roles listed on this page.
Who does Pontifax invest alongside?
The investors that hold the most companies together with Pontifax: OrbiMed, Kurma Partners, RA Capital Management, aMoon, Aisling Capital.
How this page is made
A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.
Sources: its portfolio page, read Oct 3
Pontifax portfolio: 54 known companies. Alion, Oct 15, 2026. https://alion.io/company/pontifax/portfolio
